By Bunmi Yekini HIV advocacy group PrEP4All has commended global efforts to expand access to lenacapavir, while criticizing Gilead Sciences for failing…
By Bunmi Yekini The British Association for Sexual Health and HIV (BASHH) and the British HIV Association (BHIVA) have released their long-awaited…
U=U University Launched at AIDS 2024, Paving the Way to End HIV Stigma and Achieve Global Health Milestones
1 Mins read
By Bunmi Yekini At the recent AIDS 2024 conference in Munich, a pivotal new initiative, U=U University, was unveiled to boost global…
By: Bunmi Yekini In an unexpected twist, a drug commonly used to treat type 2 diabetes may soon play a critical role…
Young Women in Africa Weigh HIV Prevention Options Through Hands-On Experience in Groundbreaking Study
2 Mins read
By: Bunmi Yekini A new study conducted across three African countries has shed light on how adolescent girls and young women (AGYW)…
By: Bunmi Yekini A recent study published in the Journal of Antimicrobial Chemotherapy reveals that the price of lenacapavir, a promising HIV…
